IBDEI15E ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18637,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18637,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,18637,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,18638,0)
 ;;=I21.3^^64^833^87
 ;;^UTILITY(U,$J,358.3,18638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18638,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,18638,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,18638,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,18639,0)
 ;;=I44.30^^64^833^49
 ;;^UTILITY(U,$J,358.3,18639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18639,1,3,0)
 ;;=3^Atrioventricular Block,Unspec
 ;;^UTILITY(U,$J,358.3,18639,1,4,0)
 ;;=4^I44.30
 ;;^UTILITY(U,$J,358.3,18639,2)
 ;;=^5007204
 ;;^UTILITY(U,$J,358.3,18640,0)
 ;;=I50.40^^64^833^58
 ;;^UTILITY(U,$J,358.3,18640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18640,1,3,0)
 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,18640,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,18640,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,18641,0)
 ;;=I50.30^^64^833^59
 ;;^UTILITY(U,$J,358.3,18641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18641,1,3,0)
 ;;=3^Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,18641,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,18641,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,18642,0)
 ;;=I50.20^^64^833^88
 ;;^UTILITY(U,$J,358.3,18642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18642,1,3,0)
 ;;=3^Systolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,18642,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,18642,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,18643,0)
 ;;=I20.0^^64^833^89
 ;;^UTILITY(U,$J,358.3,18643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18643,1,3,0)
 ;;=3^Unstable Angina
 ;;^UTILITY(U,$J,358.3,18643,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,18643,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,18644,0)
 ;;=M32.12^^64^833^80
 ;;^UTILITY(U,$J,358.3,18644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18644,1,3,0)
 ;;=3^Pericarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,18644,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,18644,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,18645,0)
 ;;=I50.811^^64^833^3
 ;;^UTILITY(U,$J,358.3,18645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18645,1,3,0)
 ;;=3^AC Right Heart Failure
 ;;^UTILITY(U,$J,358.3,18645,1,4,0)
 ;;=4^I50.811
 ;;^UTILITY(U,$J,358.3,18645,2)
 ;;=^5151385
 ;;^UTILITY(U,$J,358.3,18646,0)
 ;;=I50.813^^64^833^7
 ;;^UTILITY(U,$J,358.3,18646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18646,1,3,0)
 ;;=3^AC on Chr Right Heart Failure
 ;;^UTILITY(U,$J,358.3,18646,1,4,0)
 ;;=4^I50.813
 ;;^UTILITY(U,$J,358.3,18646,2)
 ;;=^5151387
 ;;^UTILITY(U,$J,358.3,18647,0)
 ;;=I50.812^^64^833^56
 ;;^UTILITY(U,$J,358.3,18647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18647,1,3,0)
 ;;=3^Chr Right Heart Failure
 ;;^UTILITY(U,$J,358.3,18647,1,4,0)
 ;;=4^I50.812
 ;;^UTILITY(U,$J,358.3,18647,2)
 ;;=^5151386
 ;;^UTILITY(U,$J,358.3,18648,0)
 ;;=I50.84^^64^833^61
 ;;^UTILITY(U,$J,358.3,18648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18648,1,3,0)
 ;;=3^End Stage Heart Failure
 ;;^UTILITY(U,$J,358.3,18648,1,4,0)
 ;;=4^I50.84
 ;;^UTILITY(U,$J,358.3,18648,2)
 ;;=^5151391
 ;;^UTILITY(U,$J,358.3,18649,0)
 ;;=I50.810^^64^833^66
 ;;^UTILITY(U,$J,358.3,18649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18649,1,3,0)
 ;;=3^Heart Failure,Right,Unspec
